La protonterapia debuta en España de la mano del mejor talento médico internacional
La protonterapia española de Quirónsalud Madrid en las manos del mejor talento médico internacional, el único centro de estas características en España.
Related Articles
Ibero Hemo 2025
Del 23 al 26 de abril del 2025 Centro de Convenciones de la CONMEBOL – Asunción, Paraguay Centro de Convenciones de la CONMEBOL. Asunción, Paraguay…
Ibero Hemo 2025
Del 23 al 26 de abril del 2025 Centro de Convenciones de la CONMEBOL – Asunción, Paraguay Centro de Convenciones de la CONMEBOL. Asunción, Paraguay…
Hematological Malignancies in Older Patients: Focus on the Potential Role of a Geriatric Assessment Management
Geriatric assessment management is a multidimensional tool used to evaluate prognosis for clinical outcomes and targets for interventions in older adults with cancer receiving chemotherapy.…
Management of Hematological Cancer in Older People
Department of Palliative Care, University Hospital Jena, Jena, Germany St Helens Teaching Hospital, University of Liverpool, St Helens, United Kingdom Draws from an international pool…
A comprehensive approach to therapy of haematological malignancies in older patients
Haematological malignancies are a heterogeneous group of diseases with diverse incidence. In Europe, the median age at diagnosis across all disease entities is 69 years.…
Tailoring Therapy in Older Adults With Hematologic Malignancies
Hematologic malignancies most often present in the sixth or seventh decade of life. Even so, many older adults may be unable to tolerate standard chemotherapy…
Geriatric assessment in older patients with a hematologic malignancy: a systematic review
The aim of this systematic review is to give an update of all currently available evidence on the relevance of a geriatric assessment in the…
Hematological Malignancies in Older Patients: Focus on the Potential Role of a Geriatric Assessment Management
Geriatric assessment management is a multidimensional tool used to evaluate prognosis for clinical outcomes and targets for interventions in older adults with cancer receiving chemotherapy.…
HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma
Key PointsCART30 with high proportion of less-differentiated memory T cells favors expansion and long-term persistence of memory CART30 cells.CART30 was us
How we treat mantle cell lymphoma with cellular therapy in 2025: the European and American perspectives
Bone Marrow Transplantation – How we treat mantle cell lymphoma with cellular therapy in 2025: the European and American perspectives